World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
92
Citations
40698
World Ranking
11129
National Ranking
438

Willem E. Fibbe publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Willem E. Fibbe sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 379 publications — 34th percentile

34% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Willem E. Fibbe D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Willem E. Fibbe sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 92 D-Index — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Willem E. Fibbe is affiliated with Leiden University Medical Center in the Netherlands. Their research primarily spans the field of Medicine with a focus on Genetics, Surgery, Hematology, Immunology, and Oncology as subfields of study.

The scientist's main research interests include mesenchymal stem cell research, tissue engineering and regenerative medicine, pancreatic function and diabetes, hematopoietic stem cell transplantation, CAR-T cell therapy research, biomedical ethics and regulation, and renal transplantation outcomes and treatments.

Willem E. Fibbe has contributed to several recent publications, including:

  • Safety and Preliminary Efficacy of Mesenchymal Stromal Cell (ORBCEL-M) Therapy in Diabetic Kidney Disease: A Randomized Clinical Trial (NEPHSTROM), 2023, Journal of the American Society of Nephrology
  • Human leukocyte antigen selected allogeneic mesenchymal stromal cell therapy in renal transplantation: The Neptune study, a phase I single-center study, 2020, American Journal of Transplantation
  • Autologous bone marrow-derived mesenchymal stromal cell therapy with early tacrolimus withdrawal: The randomized prospective, single-center, open-label TRITON study, 2021, American Journal of Transplantation
  • Cytokine Mixtures Mimicking the Local Milieu in Patients with Inflammatory Bowel Disease Impact Phenotype and Function of Mesenchymal Stromal Cells, 2022, Stem Cells Translational Medicine
  • A unique immune signature in blood separates therapy-refractory from therapy-responsive acute graft-versus-host disease, 2022, Blood

Their frequent coauthors include Melissa van Pel, Dominique Bonnet, Simón Méndez-Ferrer, Sjaak Philipsen, and Jan Jacob Schuringa.

Willem E. Fibbe regularly publishes in scientific journals such as:

  • Journal of the American Society of Nephrology
  • American Journal of Transplantation
  • Blood
  • Experimental Hematology
  • Stem Cells Translational Medicine

Best Publications

  • Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study.

    Katarina Le Blanc;Francesco Frassoni;Lynne Ball;Franco Locatelli

  • Immunomodulatory properties of mesenchymal stromal cells.

    Alma J. Nauta;Willem E. Fibbe

  • Isolation of Mesenchymal Stem Cells of Fetal or Maternal Origin from Human Placenta

    Pieternella S. in 't Anker;Sicco A. Scherjon;Carin Kleijburg‐van der Keur;Godelieve M.J.S. de Groot‐Swings

  • Mesenchymal stromal cells: sensors and switchers of inflammation.

    Maria Ester Bernardo;Willem E. Fibbe

  • Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation

    Pieternella S. in `t Anker;Sicco A. Scherjon;Carin Kleijburg-van der Keur;Willy A. Noort

  • Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins

    A. H. Schinkel;U. Mayer;E. Wagenaar;C. A. A. M. Mol

  • Mesenchymal Stem Cells Inhibit Generation and Function of Both CD34+-Derived and Monocyte-Derived Dendritic Cells

    Alma J. Nauta;Alwine B. Kruisselbrink;Ellie Lurvink;Roel Willemze

  • Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting

    Alma J. Nauta;Geert Westerhuis;Alwine B. Kruisselbrink;Ellie G. A. Lurvink

  • Sarcoma derived from cultured mesenchymal stem cells

    Jakub Tolar;Alma J. Nauta;Mark J. Osborn;Angela Panoskaltsis Mortari

  • Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis: A Randomized Clinical Trial

    J.M. van Laar;D. Farge;J.K. Sont;K. Naraghi

  • Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study

    Marjolijn Duijvestein;Anne Christine W Vos;Helene Roelofs;Manon E Wildenberg

  • Human fetal lymphoid tissue–inducer cells are interleukin 17–producing precursors to RORC + CD127 + natural killer–like cells

    Tom Cupedo;Natasha K Crellin;Natalie Papazian;Elwin J Rombouts

  • Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation.

    Lynne M. Ball;Maria Ester Bernardo;Helene Roelofs;Arjan Lankester

  • Mesenchymal stem cells in human second-trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential

    in 't Anker Ps;Noort Wa;Scherjon Sa;Kleijburg-van der Keur C

  • Mesenchymal stem cells promote engraftment of human umbilical cord blood–derived CD34+ cells in NOD/SCID mice

    Willy A Noort;Alwine B Kruisselbrink;Pieternella S in't Anker;Marjolein Kruger

  • Adipose Tissue-Derived Multipotent Stromal Cells Have a Higher Immunomodulatory Capacity Than Their Bone Marrow-Derived Counterparts

    Sara M. Melief;Jaap Jan Zwaginga;Willem E. Fibbe;Helene Roelofs

  • International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials

    Jacques Galipeau;Mauro Krampera;John Barrett;Francesco Dazzi

  • Isolation of functionally distinct mesenchymal stem cell subsets using antibodies against CD56, CD271, and mesenchymal stem cell antigen-1

    Venkata Lokesh Battula;Sabrina Treml;Petra M. Bareiss;Friederike Gieseke

  • Risk of tumorigenicity in mesenchymal stromal cell-based therapies--bridging scientific observations and regulatory viewpoints.

    Lisbeth Barkholt;Lisbeth Barkholt;Egbert Flory;Egbert Flory;Veronika Jekerle;Sophie Lucas-Samuel

  • Multipotent Stromal Cells Induce Human Regulatory T Cells Through a Novel Pathway Involving Skewing of Monocytes Toward Anti-inflammatory Macrophages

    Sara M. Melief;Ellen Schrama;Martijn H. Brugman;Machteld M. Tiemessen

Frequent Co-Authors

Roel Willemze
Roel Willemze Leiden University Medical Center
Martin J. Schalij
Martin J. Schalij Leiden University Medical Center
Jaap Jan Zwaginga
Jaap Jan Zwaginga Leiden University Medical Center
Jeroen J. Bax
Jeroen J. Bax Leiden University Medical Center
Frank J.T. Staal
Frank J.T. Staal Leiden University Medical Center
Ghislain Opdenakker
Ghislain Opdenakker Rega Institute for Medical Research
Albert de Roos
Albert de Roos Leiden University Medical Center
J.H. Frederik Falkenburg
J.H. Frederik Falkenburg Leiden University Medical Center
Anneke Brand
Anneke Brand Leiden University Medical Center
Katarina Le Blanc
Katarina Le Blanc Karolinska University Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in medicine but seeking flexible or alternative career pathways, online healthcare degrees offer new possibilities. The healthcare field is expanding, and careers in administration, pharmacy, and advanced nursing can be accessed through affordable online programs.

Many opt for the cheapest online healthcare administration degree to gain foundational knowledge in hospital management, policy, and health systems. For those with a bachelor’s who want to advance, a master's in healthcare administration online can open doors to higher-level leadership roles.

Nursing professionals can pursue dnp online programs cheap to reach the highest clinical practice level, often with more flexible schedules than traditional programs. Future pharmacists can benefit from exploring the true online pharmacy school cost to make informed decisions about pursuing a PharmD.

Exploring these options can greatly expand your career opportunities in health care—even if becoming a physician isn’t your only goal.

Best Scientists Citing Willem E. Fibbe

Trending Scientists

Recently Published Articles